<?xml version="1.0" encoding="UTF-8" ?>

    <journal>
    <language>en</language>
    <journal_id_issn>2008-2835</journal_id_issn>
    <journal_id_issn_online>2008-4625</journal_id_issn_online>
    <journal_id_pii></journal_id_pii>
    <journal_id_doi></journal_id_doi>
    <journal_id_isnet></journal_id_isnet>
    <journal_id_iranmedex>276</journal_id_iranmedex>
    <journal_id_magiran>5669</journal_id_magiran>
    <journal_id_sid>11181</journal_id_sid>
    <pubdate>
	    <type>gregorian</type>
	    <year>>2019</year>
	    <month>>April-June</month>
	    <day></day>
    </pubdate>
    <volume>11</volume>
    <number>2</number>
    <publish_type>online</publish_type>
    <publish_edition>1</publish_edition>
    <article_type>fulltext</article_type>
    <articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>31057716</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>CRISPR/Cas9 System for Efficient Genome Editing and Targeting in the Mouse NIH/3T3 Cells</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: The Clustered, Regularly Interspaced, Short Palindromic Repeats (CRISPR) and CRISPR-associated protein (Cas) system has been used as a powerful tool for genome engineering. In this study, the application of this system is reported for targeting &lt;em&gt;Rag&lt;/em&gt; genes to produce mutant mouse NIH/3T3 cell line. The &lt;em&gt;Rag1&lt;/em&gt; and &lt;em&gt;Rag2&lt;/em&gt; genes are essential for generation of mature B and T lymphocytes. Disruption of &lt;em&gt;Rag&lt;/em&gt; genes causes disease like Severe Combined Immunodeficiency syndrome (SCID). Here, the efficiency and specificity of CRISPR system were tested with highly active sgRNAs to generate novel mutations in the NIH/3T3 mouse cell line.&lt;br /&gt;
Methods: Four single guide RNAs were designed to target sequences in the coding region of the &lt;em&gt;Rag1&lt;/em&gt; and &lt;em&gt;Rag2&lt;/em&gt; genes. Four sgRNA-CAS9 plasmids were tested to target &lt;em&gt;Rag1&lt;/em&gt; and &lt;em&gt;Rag2&lt;/em&gt;.&amp;nbsp;&lt;br /&gt;
Results: Based on T7 endonuclease assay and sequencing analysis, the expression of sgRNAs targeting two sites in &lt;em&gt;Rag1&lt;/em&gt; resulted in deletion of the intervening DNA fragment. The expression of sgRNAs with Cas9 targeting two sites in &lt;em&gt;Rag2 &lt;/em&gt;gene resulted in indel mutations at both sites. In this report, fragment deletion in &lt;em&gt;Rag1&lt;/em&gt;&amp;nbsp;gene was detected in about 50% of transfected cells.&lt;br /&gt;
Conclusion: Therefore, CRISPR/Cas9 system can be highly efficient and specific when gRNAs are designed rationally and provides a powerful approach for genetic engineering of cells and model animals.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Cell line, Deletion, Gene editing, Mice</keyword>
	<start_page>149</start_page>
	<end_page>155</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=10369</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/10369.pdf</pdf_url>
	<author_list><author><first_name>Maryam</first_name><middle_name></middle_name><last_name>Mehravar</last_name><suffix></suffix><affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>11472</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Abolfazl</first_name><middle_name></middle_name><last_name>Shirazi</last_name><suffix></suffix><affiliation>Research Institute of Animal Embryo Technology, Shahrekord University, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>82</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mohammad Mehdi</first_name><middle_name></middle_name><last_name>Mehrazar</last_name><suffix></suffix><affiliation>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>11473</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mahboobeh</first_name><middle_name></middle_name><last_name>Nazari</last_name><suffix></suffix><affiliation>Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>11474</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mehdi</first_name><middle_name></middle_name><last_name>Banan</last_name><suffix></suffix><affiliation>Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>1152</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

